Regulations.gov document
2023-002272 - Wooshin Industrial Co Ltd - 1 - Rg3 Black Ginseng Signature - Supports…
Other · FDA-2023-S-0024 · posted Feb 16, 2024
Key facts
| Document ID | FDA-2023-S-0024-0977 |
|---|---|
| Title | 2023-002272 - Wooshin Industrial Co Ltd - 1 - Rg3 Black Ginseng Signature - Supports Immune Function and anti-oxidant activity, relief from fatigue and maintain healthy blood flow by inhibiting blood coagulation of platelet. |
| Document type | Other |
| Subtype | 30 Day Structured Function Claim |
| Agency | FDA |
| Docket | FDA-2023-S-0024 |
| Posted | Feb 16, 2024 |
| Comment period opens | Feb 16, 2024 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: